The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
ILUMYA (tildrakizumab) is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.